Search Results

Containing any of the words

Only of the type

A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 12 Years of Age with Hyperkalaemia (EMERALD2) Drug Clinical Trial

Randomized, Phase 3, double-blind, 52-week study to evaluate the efficacy and safety of rilzabrutinib (SAR444671) compared to placebo in adult participants with active IgG4- related disease Drug Clinical Trial

Egypt Country

Results and studies of marketed pharmaceutical products Lists

7-1205-2017 Marketed Products

161-9-19 Marketed Products

6-1205-2017 Marketed Products

Recalled all batches for some products produced by Achievement Scope Company for Industry Drugs Circulars and withdrawal

Brazil Country

France Country